SCHEMBL17126856

SCHEMBL17126856

CCCOc1cc2ccc(Oc3ccc(C(=O)C(SCCOCC)C(C)(C)C)cc3)cc2cc1OCCC

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ ACACB O00763 3/20 0.32
▸ ACACA Q13085 2/20 0.32
▸ SLC2A1 P11166 1/20 0.32
▸ ADRB2 P07550 1/20 0.31
▸ ADRB1 P08588 1/20 0.31
▸ ADRB3 P13945 1/20 0.31
▸ PPARG P37231 1/20 0.31
▸ PPARD Q03181 1/20 0.31
▸ PPARA Q07869 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ PLK1 P53350 1/20 0.31
▸ MTNR1A P48039 1/20 0.31
▸ MTNR1B P49286 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126863 0.93 ACACB (0.37) SMN1; SMN2MEN1LMNAMAPTMAPK1
SCHEMBL17126864 0.90 SCN9A (0.33) SMN1; SMN2MEN1LMNAMAPTKMT2A
SCHEMBL17127022 0.87 PTGS2 (0.38) SMN1; SMN2MEN1LMNAKMT2ASCN9A
SCHEMBL17126862 0.87 AKR1C3 (0.39) SMN1; SMN2LMNASCN9ASLC2A1MTNR1A
SCHEMBL17127019 0.83 LMNA (0.41) SMN1; SMN2LMNAMAPTKMT2ASLC2A1
SCHEMBL17127331 0.83 CNR2 (0.42) PPARGPPARA
SCHEMBL17126976 0.81 PPARA (0.40) SMN1; SMN2PPARGPPARDPPARALTA4H
SCHEMBL17126973 0.81 SMN1; SMN2 (0.43) SMN1; SMN2MEN1LMNAMAPTMAPK1
SCHEMBL17127023 0.81 KDM4E (0.37) SMN1; SMN2MEN1LMNAMAPTMAPK1
SCHEMBL17777239 0.80 SLC2A1 (0.48) SMN1; SMN2MEN1KMT2ASLC2A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS SMN1; SMN2 2675/4885MEN1 3840/4885LMNA 2937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback